Humana jumps 14.4% on Medicare ratings
Compartilhar
Humana (NYSE:HUM) shares jumped 14.4% to $443 in premarket trading after U.S. government data showed 95% of its members were in Medicare Advantage plans rated four stars or higher for 2027.
Humana (NYSE:HUM) shares jumped 14.4% to $443 in premarket trading after U.S. government data showed 95% of its members were in Medicare Advantage plans rated four stars or higher for 2027.
On this episode of Stock Movers: - Humana (HUM) is sinking after the insurer maintained its yearly profit guidance despite a strong second quarter. - P&G (PG) shares are moving after it gave a conservative outlook for its current fiscal year and results in the latest quarter fell short of estimates. - Kering (PPRUY) shares jumped after the luxury goods maker reported better-than-expected revenue at Gucci in the second quarter.
Humana (NYSE:HUM) reported second-quarter 2026 adjusted earnings of $7.61 per share alongside GAAP earnings of $5.73 per share.
Humana (NYSE:HUM) shares suffered their worst rout in years Tuesday, plunging 20.6% after the Trump administration proposed a nearly flat reimbursement rate for Medicare Advantage plans in 2027, a move that blindsided Wall Street and cast a shadow over the industry’s profit outlook.
Humana (NYSE:HUM) reported financial results for the first quarter ended March 31, 2026, on Wednesday morning, delivering earnings that reached the upper bound of management’s previous forecasts.
Humana (NYSE:HUM) issued a sobering outlook for 2026, projecting that a significant drop in government bonus payments will weigh on its bottom line even as the insurer sees a massive rebound in customer acquisition.
